Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism
- PMID: 27332705
- PMCID: PMC4917254
- DOI: 10.1371/journal.pone.0157700
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism
Abstract
Extracts of the pepper plant kava (Piper methysticum) are effective in alleviating anxiety in clinical trials. Despite the long-standing therapeutic interest in kava, the molecular target(s) of the pharmacologically active constituents, kavalactones have not been established. γ-Aminobutyric acid type A receptors (GABAARs) are assumed to be the in vivo molecular target of kavalactones based on data from binding assays, but evidence in support of a direct interaction between kavalactones and GABAARs is scarce and equivocal. In this study, we characterised the functional properties of the major anxiolytic kavalactone, kavain at human recombinant α1β2, β2γ2L, αxβ2γ2L (x = 1, 2, 3 and 5), α1βxγ2L (x = 1, 2 and 3) and α4β2δ GABAARs expressed in Xenopus oocytes using the two-electrode voltage clamp technique. We found that kavain positively modulated all receptors regardless of the subunit composition, but the degree of enhancement was greater at α4β2δ than at α1β2γ2L GABAARs. The modulatory effect of kavain was unaffected by flumazenil, indicating that kavain did not enhance GABAARs via the classical benzodiazepine binding site. The β3N265M point mutation which has been previously shown to profoundly decrease anaesthetic sensitivity, also diminished kavain-mediated potentiation. To our knowledge, this study is the first report of the functional characteristics of a single kavalactone at distinct GABAAR subtypes, and presents the first experimental evidence in support of a direct interaction between a kavalactone and GABAARs.
Conflict of interest statement
Figures
Similar articles
-
High-Dose Benzodiazepines Positively Modulate GABAA Receptors via a Flumazenil-Insensitive Mechanism.Int J Mol Sci. 2021 Dec 21;23(1):42. doi: 10.3390/ijms23010042. Int J Mol Sci. 2021. PMID: 35008465 Free PMC article.
-
Involvement of the GABAA receptor α subunit in the mode of action of etifoxine.Pharmacol Res. 2019 Jul;145:104250. doi: 10.1016/j.phrs.2019.04.034. Epub 2019 May 3. Pharmacol Res. 2019. PMID: 31059790
-
In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.Chem Biol Interact. 2022 Apr 25;357:109883. doi: 10.1016/j.cbi.2022.109883. Epub 2022 Mar 9. Chem Biol Interact. 2022. PMID: 35278473 Free PMC article.
-
Therapeutic potential of kava in the treatment of anxiety disorders.CNS Drugs. 2002;16(11):731-43. doi: 10.2165/00023210-200216110-00002. CNS Drugs. 2002. PMID: 12383029 Review.
-
[Kava-kava preparations--alternative anxiolytics].Pol Merkur Lekarski. 1998 Mar;4(21):179-180a. Pol Merkur Lekarski. 1998. PMID: 9640076 Review. Polish.
Cited by
-
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Ment Health Clin. 2023 Oct 2;13(5):244-254. doi: 10.9740/mhc.2023.10.244. eCollection 2023 Oct. Ment Health Clin. 2023. PMID: 38131058 Free PMC article. Review.
-
Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.Nutrients. 2023 Oct 28;15(21):4586. doi: 10.3390/nu15214586. Nutrients. 2023. PMID: 37960239 Free PMC article. Clinical Trial.
-
Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.Exp Neurol. 2023 Feb;360:114294. doi: 10.1016/j.expneurol.2022.114294. Epub 2022 Dec 6. Exp Neurol. 2023. PMID: 36493860 Free PMC article.
-
Engineered biosynthesis of plant polyketides by type III polyketide synthases in microorganisms.Front Bioeng Biotechnol. 2022 Oct 14;10:1017190. doi: 10.3389/fbioe.2022.1017190. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36312548 Free PMC article. Review.
-
Intrinsic Ability of the β-Oxidation Pathway To Produce Bioactive Styrylpyrones.Angew Chem Int Ed Engl. 2022 Aug 22;61(34):e202206851. doi: 10.1002/anie.202206851. Epub 2022 Jul 13. Angew Chem Int Ed Engl. 2022. PMID: 35726672 Free PMC article.
References
-
- Global status report on alcohol and health 2014. World Health Organization: 2014.
-
- McDonald D, Jowitt A. Kava in the Pacific Islands: a contemporary drug of abuse? Drug and Alcohol Review. 2000;19(2):217–27. 10.1080/713659319 - DOI
-
- Arkowitz H, Lilienfeld SO. Can herbs ease anxiety and depression? Scientific American Mind. 2013:72–3.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources